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538–40.Acute and
Recurrent Pericarditis
Still Idiopathic?Cremer et al. (1) underlined relevant clinical points
and the role of cardiac magnetic resonance in their
excellent review. The authors also raised important
issues concerning pathogenesis, with which we
agree and wish to expand.
The term idiopathic pericarditis seems unfortunate
in both the ﬁrst attack and in recurrences and a label
of our diagnostic ignorance or unwillingness to search
for it. In a biopsy study including 259 patients with
large pericardial effusion, the underlying cause was
identiﬁed by molecular and immunity-histological
methods: 12% viral, 35% autoreactive/lymphocytic,
2% bacterial, 15% traumatic, 28% malignant, and 8%
other (2). On the other hand, the term idiopathic may
be reassuring for the physician but may alarm the
patient, who does not understand why all the other
diseases, such as hypertension, rheumatoid arthritis,
and others, are not idiopathic, whereas their disease
is. In acute pericarditis, most cases of idiopathic
pericarditis are viral in the ﬁrst attacks, whereas
recurrences are often due to too rapidly tapered
drug regimen. Other cases seem immune mediated
or autoinﬂammatory. Possible noninvasive clues
for autoimmunity are antinuclear (3) or antiheart (4)
antibodies (50% of adults), dry eyes, arthralgias, and
a subacute course. Conversely, clues for an
autoinﬂammatory pathogenesis involving a pivotal
role for inﬂammosome are acute attacks followed
by complete resolution, strikingly elevated
C-reactive protein, high fever, and pleuropulmonary
and systemic involvement; these patients are
generally antinuclear-antibodies negative. A recentDownloaded for Anonymous User (n/a) at ASST Pa
For personal use only. No other uses withourandomized controlled trial showed that anakinra
has a spectacular effect in these patients (5), and the
term idiopathic seems inappropriate for a disease
treated with anti-interleukin-1 agents.
The pathogenesis of pericarditis is now comparable
to most other inﬂammatory diseases, and we may
consider abandoning the term idiopathic also in this
condition.Antonio Brucato, MD
*Anna Valenti, MD
Bernhard Maisch, MD
*Medicina Interna Ospedale Papa Giovanni XXIII
(Torre 4 Piano 4)
Piazza OMS 1
24127 Bergamo
Italy
E-mail: avalenti@asst-pg23.it
http://dx.doi.org/10.1016/j.jacc.2017.02.072
Please note: The authors have reported that they have no relationships relevant
to the contents of this paper to disclose.REF ER ENCES
1. Cremer PC, Kumar A, Kontizas A, et al. Complicated pericarditis. J Am Coll
Cardiol 2016;68:2311–28.
2. Maisch B, Rupp H, Ristic A, et al. Pericardioscopy and epi- and peri-
cardial biopsy- a new window to the heart improving etiological diagnoses
and permitting targeted intrapericardial therapy. Heart Fail Rev 2013;18:
317–28.
3. Imazio M, Brucato A, Doria A, et al. Antinuclear antibodies in recurrent
idiopathic pericarditis: prevalence and clinical signiﬁcance. Int J Cardiol 2009;
136:289–93.
4. Caforio AL, Brucato A, Imazio M, et al. Anti-heart and anti-intercalated disk
autoantibodies: evidence for autoimmunity in idiopathic recurrent acute
pericarditis. Heart 2010;96:779–84.
5. Brucato A, Imazio M, Gattorno M, et al. Effect of anakinra on recurrent
pericarditis among patients with colchicine resistance and corticosteroid
dependence. JAMA 2016;31:1906–12.REPLY: Acute and Recurrent Pericarditis
Still Idiopathic?Dr. Brucato and colleagues raise an important issue in
the nomenclature of pericardial disease: diagnoses of
most patients with acute or recurrent pericarditis are
labeled idiopathic. As the authors note, the term
idiopathic elicits a sense of complacency among
physicians. For patients, the response is the opposite.
They feel frustrated and alarmed that their clinicians
seem to know so little about their disease. Given this
predicament, why has idiopathic persisted in peri-
carditis, and what should the criteria be to abandon
the term?
Conventionally, excluding patients with cardiac
injury syndromes and underlying autoimmune dis-
ease, most patients’ conditions are referred to aspa Giovanni XXIII from ClinicalKey.com by Elsevier on June 13, 2017.
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juxtaposition has reﬂected that we understand the
initial cause, a viral infection, but not much regarding
the subsequent course. Speciﬁcally, the term viral
alone is unsatisfactory. Most patients with a viral
infection, such as Coxsackievirus disease, do not
develop pericarditis. Among patients who do, the
severity of disease is highly heterogeneous. In addi-
tion, identifying the causative virus is generally not a
productive endeavor, given the lack of treatment
implications. Moreover, recurrences are usually not
heralded by repeated viral infections. Often, they
occur due to rapid tapering of anti-inﬂammatory
drugs.
However, as we and others have highlighted (1,2),
the understanding of the underlying pathophysiology
of pericarditis has recently improved. In particular,
certain patients have a diathesis toward an exuberant
autoinﬂammatory response, often initiated by a viral
agent. From a practical perspective, however, any
change in nomenclature should be relatable to the
clinician and patient in terms of management.
Fortunately, therapies that target the inﬂammasome
have established (3) and emerging (4) efﬁcacy in this
disease. Therefore, we agree with Dr. Brucato and
colleagues that it is time to consider abandoning theDownloaded for Anonymous User (n/a) at ASST Papa Giovanni XXIII from
For personal use only. No other uses without permission. Copyrightterm idiopathic, and we prefer autoinﬂammatory
acute or recurrent pericarditis.Paul C. Cremer, MD
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